12:00 PM - 1:15 PM PST
Location: Zoom Webinar
Registration ends on 2/4/2026
The Washington Patient Safety Coalition is hosting a webinar to recruit hospitals to participate in a National Study: Over-Goal Blood Transfusion.
When: February 4, 2026, noon-1 PM PT, via Zoom
Description: The study, in conjunction with Case Western Reserve University, is actively enrolling hospitals to study the percent of red blood cell (RBC) transfusions that exceed restrictive transfusion guidelines.
Educational Goals: This presentation will discuss study requirements and benefits. People attending this presentation will learn about enhanced measures of appropriate blood use, and how to immediately and effectively address RBC transfusion issues.
Who should attend: Administration executives, quality managers, laboratory administrators, and blood bank directors/managers.
Speaker Bio: The presentation will be delivered by David F. Jadwin, DO, FCAP, Director, Columbia Healthcare Analytics. Inc. David’s career spans 57 years and has included many national presentations on quality and blood management. He is the current chief study investigator and is developing AI clinical decision support to safely improve blood transfusions. Current pilot studies are being trialed in Uganda, to provide electronic health records to LMICs.
Benefits: Hospitals participating in the study will receive interpreted comparative transfusion metrics, benchmarked against national data. There is no cost to participate in this study, and data participation requirements are simple, typically requiring just a few hours of IT project management time. No protected health information is required and all participants are anonymized. The study anticipates that at least 30 percent of patients being transfused can likely be managed without transfusion, reducing RBC use by 30-40 percent.
Background: Current restrictive transfusion guidelines, in the absence of significant bleeding, state to “consider” RBC transfusion if the hemoglobin (Hb) is < 7 g/dL. Guidelines sometimes extend to <8 g/dL, in certain situations, but the benefits of transfusion at > 7 g/dL are uncertain. Often, appropriate patient blood management is lacking, resulting in default RBC transfusion, which otherwise could have likely been managed by PBM alone.
A study published in 2023 found that 45 percent of patients transfused likely could have been managed without transfusion. Determination of Unnecessary Blood Transfusion by Comprehensive 15-Hospital Record Review A follow-up study (49 hospitals, 284k patients, 930k RBC transfusions) has confirmed this finding, which now leads to the current study. The current study will further evaluate the extent of unnecessary RBC use and developed enhanced metrics.